Funder
National Institute of General Medical Sciences
National Center for Advancing Translational Sciences
National Cancer Institute
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference54 articles.
1. Albain K, Anderson S, Arriagada R, Barlow W, Bergh J, Bliss J, Buyse M, Cameron D, Carrasco E, Clarke M et al (2012) Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials. Lancet 379:432–444. https://doi.org/10.1016/S0140-6736(11)61625-5
2. Steed H, Sawyer MB (2007) Pharmacology, pharmacokinetics and pharmacogenomics of paclitaxel. Pharmacogenomics 8:803–815. https://doi.org/10.2217/14622416.8.7.803
3. Bergh J, Mariani G, Cardoso F, Liljegren A, Awada A, Vigano L, Huang X, Verkh L, Kern KA, Giorgetti C et al (2012) Clinical and pharmacokinetic study of sunitinib and docetaxel in women with advanced breast cancer. Breast 21:507–513. https://doi.org/10.1016/j.breast.2012.01.012
4. Mielke S, Sparreboom A, Behringer D, Mross K (2005) Paclitaxel pharmacokinetics and response to chemotherapy in patients with advanced cancer treated with a weekly regimen. Anticancer Res 25:4423–4427
5. Xin DS, Zhou L, Li CZ, Zhang SQ, Huang HQ, Qiu GD, Lin LF, She YQ, Zheng JT, Chen C et al (2018) TC > 0.05 as a pharmacokinetic parameter of paclitaxel for therapeutic efficacy and toxicity in cancer patients. Recent Pat Anti-Cancer Drug Discov 13:341–347. https://doi.org/10.2174/1574892813666180305170439
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献